Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iradimed (IRMD) Non-Current Assets (2016 - 2025)

Iradimed (IRMD) has disclosed Non-Current Assets for 13 consecutive years, with $27.6 million as the latest value for Q4 2025.

  • Quarterly Non-Current Assets rose 19.45% to $27.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $113.0 million through Dec 2025, up 49.64% year-over-year, with the annual reading at $27.6 million for FY2025, 19.45% up from the prior year.
  • Non-Current Assets for Q4 2025 was $27.6 million at Iradimed, down from $29.8 million in the prior quarter.
  • The five-year high for Non-Current Assets was $29.8 million in Q3 2025, with the low at $6.6 million in Q4 2021.
  • Average Non-Current Assets over 5 years is $15.4 million, with a median of $15.4 million recorded in 2023.
  • The sharpest move saw Non-Current Assets decreased 20.57% in 2021, then surged 112.21% in 2023.
  • Over 5 years, Non-Current Assets stood at $6.6 million in 2021, then grew by 20.91% to $8.0 million in 2022, then skyrocketed by 101.33% to $16.2 million in 2023, then surged by 42.89% to $23.1 million in 2024, then increased by 19.45% to $27.6 million in 2025.
  • According to Business Quant data, Non-Current Assets over the past three periods came in at $27.6 million, $29.8 million, and $29.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.